A prospective observational study was conducted over a 10-month period to determine the clinical and laboratory manifestations of cryptococcal meningitis in Zimbabwe, a country where antifungal agents are not widely available. Eighty-nine patients with cryptococcal meningitis (median age, 34 years; range, 11 -63 years; 56 males) were identified from 406 patients for whom a clinical diagnosis of meningitis had been made. All patients tested were positive for antibody to human immunodeficiency virus. Cryptococcal meningitis was the first AIDS-defining illness in 88% of patients. Typical presentations were headache, mental impairment, and meningism (median duration, 14 days; range,
Infection due to Cryptococcus neoformans, a ubiquitous en-
Zimbabwe, and thus, as in many resource-poor sub-Saharan African countries [17] , cost-benefit considerations have precapsulated fungus [1 -3] , is the third most frequent opportunistic infection of the CNS in patients with AIDS [4] . Cryptococvented the provision of these expensive drugs as a priority of health care expenditures. However, the section of society afcosis has been extensively described in patients from Europe and North America [5 -11] and has been recognized as a promifected by cryptococcal meningitis is socioeconomically very important and is often responsible for the support and care of nent AIDS-associated opportunistic infection in sub-Saharan Africa for ú10 years [12 -18] . Studies conducted largely in others [22] . This circumstance has resulted in increased demand for effective treatment and, in the absence of antifungal agents, the United States suggest that between 6% and 10% of patients with AIDS will develop cryptococcal meningitis [7, 19] . In has made it extremely difficult for the attending physician to manage patients with cryptococcal meningitis. Comprehensive 40% of these patients, cryptococcosis is the first AIDS-defining condition [6 -10, 19, 20] .
prospective studies from this region on which to base new approaches to therapy are scarce. Zimbabwe has a comprehensive list of essential drugs that covers treatment of a wide spectrum of infectious and noninfec-
The aim of this prospective study was therefore to define the clinical features, laboratory findings, immunologic status, tious conditions; this list constitutes the national formulary for government hospitals [21] . The drug list does not include and outcome for patients with cryptococcal meningitis who present to the teaching hospitals in Harare, Zimbabwe. We antifungal agents for the treatment of cryptococcosis. The cost of the initial induction phase of therapy for cryptococcal meninhave attempted to identify a group of patients with good prognoses who are suitable for targeting the development of new gitis amounts to several times the average monthly salary in treatments or novel therapeutic strategies appropriate for the region.
Consecutive patients with cryptococcal meningitis presenting for this patient population. To assess outcome, patients were followed up at home at regular intervals until death. Postto three of 10 adult general internal medical teams were identified as part of a large meningitis study conducted between 1 mortem examinations were not performed. January and 31 October 1995. The admission policy for these teams has a lower age limit of 8 years and no upper age limit.
Statistical Analysis
Meningitis was considered if the patient had meningism (signs of neck stiffness with photophobia, vomiting, or headache);
The cumulative median survival (95% CI) was calculated fever with fits, change in mental state, or headache; unexplained from the date of presentation by using the Kaplan-Meier change in mental state with either fits or headache; or a severe method. males (median age, 33 years; range, 11 -51 years). Seventy-CSF was routinely plated onto sheep blood, MacConkey, nine (100%) of 79 patients tested were positive for antibody and chocolate agars. All cryptococcal isolates were subcultured to HIV. onto Sabouraud dextrose medium, and their identity was confirmed with use of API 20 C kits (bioMérieux, Marcy l'Etoile, France). The biovar was determined by culture on glycine-L-
Clinical Features
canavanine bromothymol blue agar [26] . Cryptococcal polysaccharide antigen in CSF was detected by latex agglutination
The presenting clinical features of the patients are detailed in table 1. Cryptococcosis was the first known AIDS-defining testing (Omega Diagnostics, Alloa, United Kingdom). Anonymous serological testing for HIV was performed by using a illnesses in 78 (88%) of 89 patients. A diagnosis of active pulmonary tuberculosis (typical radiographic changes and/or a dipstick antibody screening assay (Immuno Chemical Laboratory, Bangkok, Thailand); this assay was previously shown to positive sputum smear) had been made for six patients before admission. Treatment with a standard regimen of rifampin, be sensitive and specific under local conditions [27] . Absolute CD4 / lymphocyte counts were quantified on whole blood isoniazid, pyrazinamide, and ethambutol had been commenced. Two patients had Kaposi's sarcoma, and three patients had smears by immunostaining with a mouse monoclonal antibody to CD4 (Dako, Glostrup, Denmark) that was detected by using bacteremia due to non-typhi Salmonella. At least one other feature of HIV infection was identified in 60 (75%) of 80 the alkaline phosphatase/antibody to alkaline phosphatase technique [28] .
patients examined.
The median time from the onset of symptoms to diagnosis was 14 days (range, 1 -180 days). Patients typically presented
Evaluation of Outcome
with headache, mental impairment, and features of meningism in the absence of focal neurological signs. Twenty-six (35%) In Zimbabwe, once a diagnosis of cryptococcal meningitis is made at a government hospital, patients are routinely disof 74 patients had received antimicrobial chemotherapy before admission. Extraneural manifestations of cryptococcal disease charged to the care of their families with supportive advice and analgesic treatment. Antifungal agents are not on the Essential were not identified in this cohort. Concurrent respiratory disease was identified in 30 (34%) Drugs List for Zimbabwe [21] , and although these agents are available in the private sector, they are prohibitively expensive of 89 patients, 25 of whom had an acute cough and 11 of whom / 9c46$$fe11 01-08-98 22:06:30 cidas UC: CID Patients were hospitalized for a median of 4 days (range, 0 -37 days). Fifty patients were discharged alive, 11 of whom were lost to follow-up (median follow-up, 4 days; range, 0 -had an abnormality on a chest radiograph (lobar shadowing, 7; 14 days). The cumulative median survival was 14 days (95% patchy infiltrates, 2; and interstitial shadowing, 2). Sputum CI, 9.9 -18.1; range, 0 -233 days), and 17 (22%) of 78 survived collection or bronchoalveolar lavage was not performed. It is for ú30 days. None of the patients were known to have retherefore unclear whether these clinical and radiological feaceived antiretroviral or antifungal therapy. Analysis of clinical tures constituted pulmonary cryptococcosis or intercurrent bacand laboratory features predictive of outcome revealed that terial pneumonia. severely impaired mental status -i.e., GCS of õ13 (10 of 67 patients; OR, 6.9; 95% CI, 1.5 -33; P Å 0.023) -and hyponatremia (16 of 71 patients; OR, 7.9; 95% CI, 1.6 -38; P Å .012)
Laboratory Findings
were associated with rapid deterioration following admission (survival, õ3 days). Anemia in both men (hemoglobin level, õ13 g/dL) and women (hemoglobin level, õ12 g/dL) was a common finding Both patients with coexistent P. falciparum parasitemia died on the day of admission. Neither bacteremia at the time of in this population (68% and 87%, respectively). However, only three patients had a hemoglobin level of õ8 g/dL. Twentypresentation nor a diagnosis of Kaposi's sarcoma was associated with rapid deterioration following admission. No associathree percent of the patients had hyponatremia (serum sodium level, õ128 mmol/L) at the time of admission. The cellular tion between severe mental impairment or hyponatremia and a more indolent illness (survival ú14 days) was observed. and biochemical CSF abnormalities observed were modest: median WBC count, 5/mm 3 survival of õ3 days or ú14 days (stepwise logistic regression of disease at presentation rather than immunologic differences, but this speculation remains to be confirmed. analysis).
Before the introduction of amphotericin B in the middle 1950s, an underlying immunodeficiency was absent in most Discussion patients with cryptococcal meningitis [31 -33, 37] . We and other researchers have demonstrated a profound immunodefiStoddard and Cutler [30] were the first to comprehensively ciency in HIV-infected individuals with cryptococcal meningidescribe the clinical characteristics and laboratory diagnosis tis who frequently have CD4 / cell counts of õ100/mL [4, 5, of systemic infection with C. neoformans. In a monograph 10, 29]. The modest biochemical and cytological changes seen published in 1916, they differentiated the disease from other in CSF specimens from our patients have been described in fungal infections and named the organism Torula histolytica.
HIV-infected patients elsewhere [6, 9 -11, 17]. These changes Before the epidemic of HIV infection, cryptococcal meningitis could easily be overlooked in the context of the frequently was a rare but well-recognized disease worldwide [4, 13, 19, observed abnormalities associated with invasion of HIV into 31 -35] . Reports of cryptococcal disease in HIV-infected indithe CNS alone [38] . Indeed, it is important to point out that viduals from sub-Saharan Africa appeared in the early 1980s seven (8%) of our patients for whom microbiological evidence [12, 13] . At Harare Central Hospital, there has been a 12-fold of infection had been found had no detectable CSF abnormalirise in the number of diagnoses of cryptococcal meningitis in ties. patients in the period between 1990 and 1995 (Central Hospital Current treatment regimens for cryptococcal meningitis are Statistics). This large prospective study demonstrates that associated with a high rate of acute mortality during initial C. neoformans, almost exclusively var. neoformans [1, 2, 14, therapy (10% -25%), a 12-month survival rate among all pa-36], now accounts for 45% of all laboratory-proven cases of tients of 30% -60% [4, 7, 11, 20] , and a high relapse rate meningitis in adults.
without maintenance treatment [6, 7, 9] . A number of investigaIn common with reports spanning the last 80 years [5 -11, tors have attempted to define the clinical and laboratory charac-17, 18, 31 -33], most patients with cryptococcal disease in our teristics associated with a poor prognosis to optimize antifungal study were men in their fourth decade of life (table 2). All treatment [5 -7, 9 -11, 29] . Analysis of these factors in our subjects tested were HIV-positive, and 88% presented with population revealed a high prevalence of patients younger than what was frequently their first AIDS-defining illness. As in 35 years of age, impaired mental status, hyponatremia, low previous studies conducted both before and during the era of CSF leukocyte counts, and a low CSF glucose level. With the HIV infection, these individuals were generally symptomatic exception of one patient, all individuals who completed followfor at least 2 weeks before admission with nonspecific features up had at least one poor prognostic indicator at the time of of subacute meningitis or meningoencephalitis and headache.
admission (median number of factors, 2; range, 0 -4). It is It is interesting that, as was found before the introduction of therefore remarkable that although the cumulative median suramphotericin B [31 -33] hyponatremia were associated with survival of õ3 days and 
